ClinicalTrials.govpublic full text
Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
acromegaly, gh, igf-i, tumor, lanreotide, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868194
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.